Clostridium difficile in vivo studies
Currently, there are only a few laboratories worldwide that have the capacity and expertise to work on the evaluation of C. difficile prophylactics or therapeutics.
Main Services
Contract Research
Strain constructions, genetic engineering of Bacillus, QPS and GRAS safety assessments, and more…
Regulatory Assessments
Due to the ever increasing stringency with which EFSA is imposing on the industry there is a growing realisation that the safety of a bacterial strain needs to be defined at the level of the genome.
